The Sweet Catalyst: New Wistar Institute Study Uncovers Link Between Fructose and Ovarian Cancer Metastasis on September 9, 2026 Posted by
The Gold Standard of Comfort: Why These Four Chains Rule the Buttermilk Biscuit Game on September 9, 2026 Posted by
The Human Side of Hematology: Navigating the Emotional Landscape of Multiple Myeloma on September 9, 2026 Posted by
A Potential Paradigm Shift: Baxdrostat Shows Promise in Managing Resistant Hypertension and Chronic Kidney Disease on September 9, 2026 Posted by
The Pilots Who Prepared for the Ultimate Sacrifice: Heather Penney and the 9/11 Mission That Never Was on September 9, 2026 Posted by
Bridging the Gap: Vivos Therapeutics and South Palm Cardiovascular Associates Launch Regional Sleep-Cardiology Hub on September 9, 2026 Posted by
Beyond the Brush: The Essential Role of Vitamin D in Oral and Systemic Health on September 9, 2026 Posted by
The Sweet Catalyst: New Wistar Institute Study Uncovers Link Between Fructose and Ovarian Cancer Metastasis on September 9, 2026 Posted by
The Gold Standard of Comfort: Why These Four Chains Rule the Buttermilk Biscuit Game on September 9, 2026 Posted by
The Human Side of Hematology: Navigating the Emotional Landscape of Multiple Myeloma on September 9, 2026 Posted by
A Potential Paradigm Shift: Baxdrostat Shows Promise in Managing Resistant Hypertension and Chronic Kidney Disease on September 9, 2026 Posted by
Posted in Digital Health Tools A New Horizon for Rare Disease: FDA Approval of Lisraya Marks a Turning Point for Dermatomyositis Patients on September 5, 2026
Posted in Digital Health Tools A New Era for Dermatomyositis: Roivant Sciences Secures Historic FDA Approval for Lisraya on August 28, 2026
Posted in Medical Innovations A Breakthrough for Rare Disease: FDA Approves Lisraya for Dermatomyositis on August 28, 2026
Posted in Medical Innovations A New Era in Rheumatology: FDA Approves First Oral Therapy for Dermatomyositis on August 28, 2026
Posted in Medical Innovations A New Frontier in Dermatomyositis: FDA Approval of Lisraya Marks a Pivot Point for Roivant on August 27, 2026
Posted in Medical Innovations Bridging the Gap: How New Validation of IMACS Guidelines Could Revolutionize Cancer Screening in Dermatomyositis Patients on July 11, 2026
